Acumen Pharmaceuticals Share Price (NASDAQ: ABOS)
$1.4
▲
0.04
(2.94%)
Live
Last updated on
Check the interactive Acumen Pharmaceuticals Stock chart to analyse performance
Acumen Pharmaceuticals Inc Key Stats
Check Acumen Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Acumen Pharmaceuticals Stock including INR - Dollar returns
The Acumen Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Acumen Pharmaceuticals investment value today
Current value as on today
₹54,077
Returns
Returns from Acumen Pharmaceuticals Stock
Dollar Returns*
₹4,255 (+4.25%)
Indian investors sentiment towards Acumen Pharmaceuticals Stock
Global Institutional Holdings in Acumen Pharmaceuticals Inc
Name
Holdings %
RA Capital Management, LLC
24.65%
Sands Capital Ventures, LLC
5.64%
Franklin Resources Inc
5.08%
BlackRock Inc
3.85%
FMR Inc
3.34%
Vanguard Group Inc
2.79%
Analyst Recommendation on Acumen Pharmaceuticals Stock
Buy
91%Buy
8%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Acumen Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Acumen Pharmaceuticals Share Price Target
What analysts predicted
Upside of 457.14%
Target:
$7.80
Current:
$1.40
Acumen Pharmaceuticals share price target is $7.80, a slight Upside of 457.14% compared to current price of $1.40 as per analysts' prediction.
Acumen Pharmaceuticals Stock Insights
Price Movement
In the last 1 month, ABOS stock has moved down by -18.0%ABOS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 119.5%ABOS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 114.2% return, outperforming this stock by 186.9%Price to Sales
ForABOS every $1 of sales, investors are willing to pay $41.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.6 for every $1 of sales.
Acumen Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Acumen Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Acumen Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -18.45% | -1.44% | -51.25% | -72.82% | -92.75% |
 | 4.5% | -14.59% | -49.64% | -0.73% | 0.56% |
 | 6.48% | 22.93% | 60.47% | 81.44% | 32.24% |
 | -16.69% | -17.94% | -17.2% | 38.81% | 48.58% |
 | 43.34% | 86.27% | 68.31% | 115.22% | 254.29% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 3.26 | NA | NA | -2.24 | -0.76 | -0.39 | NA | 1.93 |
| 14.9 | 14.9 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 28.01 | 28.01 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $85.4M | -92.75% | 3.26 | 0.0% |
| Buy | $62.6B | 0.56% | 14.9 | 31.37% |
| NA | $37.6B | 32.24% | NA | -3.89% |
| Buy | $101.1B | 48.58% | 28.01 | 31.86% |
| Buy | $60.1B | 254.29% | NA | -12.96% |
About Acumen Pharmaceuticals Inc
Key Management of Acumen Pharmaceuticals Inc
Important FAQs about investing in ABOS Stock from India :
What is Acumen Pharmaceuticals share price today?
Acumen Pharmaceuticals share price today is $1.40 as on . Acumen Pharmaceuticals share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
What is the 52 week high and 52 week low for Acumen Pharmaceuticals share?
Acumen Pharmaceuticals share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Acumen Pharmaceuticals stock price today i.e. is trending at $1.40, lower by 58.33% versus the 52 week high.
How to invest in Acumen Pharmaceuticals Stock (ABOS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Acumen Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acumen Pharmaceuticals Shares that will get you 1.0714 shares as per Acumen Pharmaceuticals share price of $1.40 per share as on August 23, 2025 at 12:37 AM IST.
What is the minimum amount required to buy Acumen Pharmaceuticals Stock (ABOS) from India?
Indian investors can start investing in Acumen Pharmaceuticals (ABOS) shares with as little as ₹87.499 or $1 (as of August 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.99 in Acumen Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 22, 2025).
Based on Acumen Pharmaceuticals share’s latest price of $1.40 as on August 23, 2025 at 12:37 AM IST, you will get 7.1429 shares of Acumen Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Acumen Pharmaceuticals has given to Indian investors in the last 5 years?
Acumen Pharmaceuticals stock has given -92.75% share price returns and 17.97% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
Dbv Technologies S.a. - Spons-adr$9.96
+4.4%
Sight Sciences Inc$4.12
+0.0%
Curis Inc$1.63
+4.49%
Prelude Therapeutics Inc$1.08
-1.82%
Corbus Pharmaceuticals Holdings, Inc.$10.03
+3.4%
Xeris Biopharma Holdings Inc$7.68
+1.19%
Voyager Therapeutics, Inc.$3.49
+3.87%
Sundial Growers Inc$2.27
+1.34%
Cassava Sciences Inc$2.19
+1.86%